# Fluorescein

## Fluorescite 10% 5mL

##### 

| TAH Drug Code      | IFLU10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Diagnostic fluorescein angiography or angioscopy of the fundus & iris vasculature.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Use in adults, including the elderly: Inject 5 mL of Fluorescein 10% solution for injection rapidly into the antecubital vein after taking precautions to avoid extravasation. In cases when highly sensitive imaging systems, e.g., scanning laser ophthalmoscope are used, the dose of this product should be reduced to 2 mL of Fluorescein 10% solution for injection. Use in paediatric patients: For children, the dose should be calculated on the basis of 35 mg for each 10 pounds of body weight (7.7 mg/kg body weight). |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Not for intrathecal administration. Care must be taken to avoid extravasation during injection. History of allergy or bronchial asthma. Pregnancy, especially in the 1st trimester. Lactation.                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Nausea, headache, GI distress, syncope, vomiting, hypotension, hypersensitivity. Reported cardiac arrest, basilar artery ischemia, severe shock, convulsions & thrombophlebitis at inj site. Extravasation may cause severe pain & pain at inj site. Occasionally, urticaria, itch, bronchial spasm.                                                                                                                                                                                                                                |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

